PremiumThe FlyContextLogic Inc options imply 4.8% move in share price post-earnings ContextLogic Directors Parisi and LaPuma Resign ContextLogic Appoints Jennifer Chou to Board of Directors PremiumCompany AnnouncementsContextLogic Amends Investment Agreement and Appoints New CEO ContextLogic Inc options imply 7.5% move in share price post-earnings ContextLogic Inc options imply 7.6% move in share price post-earnings PremiumCompany AnnouncementsContextLogic Enhances Leadership and Streamlines Governance Seventeen option delistings on December 20th AstraZeneca to Buy LogicBio Therapeutics for $2.07 Per Share